Ibsa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IBSA, and when can generic versions of IBSA drugs launch?
IBSA has five approved drugs.
There are seven US patents protecting IBSA drugs.
There are thirty-two patent family members on IBSA drugs in sixteen countries and one supplementary protection certificate in one country.
Summary for Ibsa
| International Patents: | 32 |
| US Patents: | 7 |
| Tradenames: | 5 |
| Ingredients: | 3 |
| NDAs: | 5 |
Drugs and US Patents for Ibsa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-010 | Oct 2, 2009 | RX | Yes | No | 7,723,390 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-002 | Dec 15, 2016 | RX | Yes | No | 11,241,382 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-005 | Dec 15, 2016 | RX | Yes | No | 11,096,913 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-007 | Oct 13, 2006 | RX | Yes | No | 7,691,411 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-003 | Oct 13, 2006 | RX | Yes | No | 7,723,390 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ibsa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-012 | Apr 25, 2017 | 7,723,390 | ⤷ Try a Trial |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-003 | Oct 13, 2006 | 7,691,411 | ⤷ Try a Trial |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-008 | Oct 2, 2009 | 7,691,411 | ⤷ Try a Trial |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-013 | Aug 1, 2007 | 7,691,411 | ⤷ Try a Trial |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-008 | Oct 2, 2009 | 7,723,390 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for IBSA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Patch | 1.3% | ➤ Subscribe | 2015-06-26 |
International Patents for Ibsa Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2019106889 | ⤷ Try a Trial |
| Canada | 3129627 | ⤷ Try a Trial |
| Austria | 447939 | ⤷ Try a Trial |
| European Patent Office | 1291021 | ⤷ Try a Trial |
| Canada | 2454050 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ibsa Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1291021 | 132012902104794 | Italy | ⤷ Try a Trial | PRODUCT NAME: LEVOTIROXINA SODICA(ALIASINT); AUTHORISATION NUMBER(S) AND DATE(S): RVG 106848; 106850-106860, 20110407;DA 041528011/M A 041528365/M, 20120808 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
